SCHEMBL73111

SCHEMBL73111

F/C=[C]/Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL73110 1.00
SCHEMBL22750844 1.00
SCHEMBL5829999 0.63
SCHEMBL1791186 0.59
SCHEMBL1791184 0.59
SCHEMBL575062 0.59
SCHEMBL575061 0.59
SCHEMBL22750854 0.59
SCHEMBL22750839 0.59
SCHEMBL575110 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773768-B1 PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS INC (US) 2018-08-22 EP disclosed
US-10053430-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORP. (US) 2018-08-21 US disclosed
EP-2410987-B1 METHODS OF TREATMENT USING COMBINATION THERAPY AMBIT BIOSCIENCES CORP (US) 2018-05-16 EP disclosed
EP-2268623-B9 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2018-02-28 EP disclosed
US-20170348320-A1 IMIDAZOLOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASE AMBIT BIOSCIENCES CORP (US) 2017-12-07 US disclosed
US-20170298029-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2017-10-19 US disclosed
EP-1844020-B1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS INC (US) 2017-09-06 EP disclosed
US-9730937-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-15 US disclosed
EP-3147281-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2017-03-29 EP disclosed
EP-2947072-B1 1-(3-(6,7-DIMETHOXYQUINAZOLIN-4-YLOXY)PHENYL)-3-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)UREA AS RAF KINASE MODULATOR IN THE TREATMENT OF CANCER DISEASES AMBIT BIOSCIENCES CORP (US) 2016-11-09 EP disclosed
EP-0932605-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINE AS HERBICIDE BAYER AG (DE) 1999-08-04 EP disclosed
EP-0932604-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES AS HERBICIDES BAYER AG (DE) 1999-08-04 EP disclosed
WO-1999037627-A1 SUBSTITUTED AMINOALKYLIDENAMINO TRIAZINES AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1999-07-29 WO disclosed
WO-1999029677-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 1999-06-17 WO disclosed
WO-1999019309-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 1999-04-22 WO disclosed
WO-1999018100-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINE AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed
WO-1998015539-A1 SUBSTITUTING 2-AMINO-4-ALKYLAMINO-1,3,5-TRIAZINE AS HERBICIDE BAYER AKTIENGESELLSCHAFT (DE) 1998-04-16 WO disclosed
WO-1998015538-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINE AS HERBICIDE BAYER AKTIENGESELLSCHAFT (DE) 1998-04-16 WO disclosed
WO-1998015536-A1 SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-16 WO disclosed
WO-1998015537-A1 SUBSTITUTED 2-AMINO-4-ALKYLAMINO-1,3,5-TRIAZINES AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-16 WO disclosed